Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Antoine Papiernik

πŸ‘€ Speaker
432 total appearances

Appearances Over Time

Podcast Appearances

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Well, I think to me, but again, I'm not the expert in that field, but if I look at what I, you know, the countries I know the best, you know, there are things that are reimbursed that should not be reimbursed.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

I mean, do I think that, and I've said this publicly before, do I think people who have a, you know, a headache go to that doctor to get a prescription for paracetamol?

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

That makes no sense to me as a citizen.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

To me, it's like, I've got a headache.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

I buy out-of-pocket paracetamol and I self-admits that paracetamol so that I hope that the day that I need something very different as a drug, then I will be able to access that drug.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

But the numbers are so vast in how many people just decide to go to their physician, get reimbursed for that, to get a prescription for a drug that you don't need a prescription for.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

I'm exaggerating.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Yeah, of course.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

So, you know, if the citizens want to be treated, they need to also start to understand that they have a responsibility in that and that they need to save, you know, their own dollars, health care dollars, euros.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

pounds, whatever, for a disease that actually will save them, not will just be a nice drug that they could get off.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

So what you may not know is that we actually opened an office in Shanghai in 2006.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

at the time probably was silly, but the idea was something needs to happen there.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

At the time, we're talking about traditional medicine, so things that were at the complete other side of the next biotech drug.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

And we didn't stay there very long because there was 2008 and we had to focus on our own country, but we have relationships today that dates back 20 years.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

And anyone who's surprised...

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

about what's happened in China just didn't do their homework because it was written.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

I have visited China several times a year over the last 20 years.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

And it's just amazing.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

what's happened there.

Vanguards of Healthcare by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

But it's not a surprise.